CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell Lymphoma
Clinical trial NCT07492407 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07492407
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-02-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.